Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis
- PMID: 29284688
- DOI: 10.1183/13993003.02023-2017
Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com
Comment in
-
Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis.Eur Respir J. 2018 Mar 22;51(3):1702187. doi: 10.1183/13993003.02187-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29567720 No abstract available.
Comment on
-
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.Eur Respir J. 2016 Apr;47(4):1235-43. doi: 10.1183/13993003.02146-2015. Epub 2016 Mar 10. Eur Respir J. 2016. PMID: 26965290
-
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.Eur Respir J. 2016 Jun;47(6):1758-66. doi: 10.1183/13993003.00214-2016. Epub 2016 Apr 13. Eur Respir J. 2016. PMID: 27076583
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources